Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Rei Yang

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Oncology Letters|June 5, 2023
Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancerCheng-Kuang Yang, Chi-Rei Yang, Yen-Chuan Ou, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 5, 2007
The 5th Conference on Asian Trends in Prostate Cancer Hormone TherapyHideyuki Akaza, Malcolm A Moore, Shu-Jen Chang, et al.
Biofactors (Oxford, England)|October 19, 2018
Alteration in serum concentrations of FGF19, FGF21, and FGF23 in patients with urothelial carcinomaJian-Ri Li, Kun-Yuan Chiu, Yen-Chuan Ou, et al.
Frontiers in Pharmacology|December 8, 2017
Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after DocetaxelJian-Ri Li, Kun-Yuan Chiu, Shian-Shiang Wang, et al.
Cancers|July 14, 2023
Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone-A Retrospective StudyHao Xiang Chen, Li-Hsien Tsai, Chao-Hsiang Chang, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 6, 2002
Asian trends in prostate cancer hormone therapyHideyuki Akaza, Seiji Naito, Christopher Cheng, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 31, 2003
The 2nd conference on Asian trends in prostate cancer hormone therapyHideyuki Akaza, Shu-Jen Chang, Kuang-Kuo Chen, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 31, 2004
The 3rd Conference on Asian Trends in Prostate Cancer Hormone TherapyHideyuki Akaza, Seiji Naito, Shu-Jen Chang, et al.
Scientific Reports|March 26, 2025
Preoperative ECOG performance status as a predictor of outcomes in upper tract urothelial cancer surgeryTsung-Mu Yang, I-Hsuan Alan Chen, Chia-Cheng Yu, et al.
World Journal of Urology|January 10, 2024
Prognostic factors of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomaChen-Ya Chen, Chao-Hsiang Chang, Chi-Rei Yang, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Oncology Letters|June 5, 2023
Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancerCheng-Kuang Yang, Chi-Rei Yang, Yen-Chuan Ou, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 5, 2007
The 5th Conference on Asian Trends in Prostate Cancer Hormone TherapyHideyuki Akaza, Malcolm A Moore, Shu-Jen Chang, et al.
Biofactors (Oxford, England)|October 19, 2018
Alteration in serum concentrations of FGF19, FGF21, and FGF23 in patients with urothelial carcinomaJian-Ri Li, Kun-Yuan Chiu, Yen-Chuan Ou, et al.
Frontiers in Pharmacology|December 8, 2017
Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after DocetaxelJian-Ri Li, Kun-Yuan Chiu, Shian-Shiang Wang, et al.
Cancers|July 14, 2023
Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone-A Retrospective StudyHao Xiang Chen, Li-Hsien Tsai, Chao-Hsiang Chang, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 6, 2002
Asian trends in prostate cancer hormone therapyHideyuki Akaza, Seiji Naito, Christopher Cheng, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 31, 2003
The 2nd conference on Asian trends in prostate cancer hormone therapyHideyuki Akaza, Shu-Jen Chang, Kuang-Kuo Chen, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 31, 2004
The 3rd Conference on Asian Trends in Prostate Cancer Hormone TherapyHideyuki Akaza, Seiji Naito, Shu-Jen Chang, et al.
Scientific Reports|March 26, 2025
Preoperative ECOG performance status as a predictor of outcomes in upper tract urothelial cancer surgeryTsung-Mu Yang, I-Hsuan Alan Chen, Chia-Cheng Yu, et al.
World Journal of Urology|January 10, 2024
Prognostic factors of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomaChen-Ya Chen, Chao-Hsiang Chang, Chi-Rei Yang, et al.
Pageof 8